Brain-specific Phgdh Deletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, an N-methyl-d-aspartate Receptor Co-agonist, in Adult Brain
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
In mammalian brain, D-serine is synthesized from L-serine by serine racemase, and it functions as an obligatory co-agonist at the glycine modulatory site of N-methyl-D-aspartate (NMDA)-selective glutamate receptors. Although diminution in D-serine level has been implicated in NMDA receptor hypofunction, which is thought to occur in schizophrenia, the source of the precursor L-serine and its role in D-serine metabolism in adult brain have yet to be determined. We investigated whether L-serine synthesized in brain via the phosphorylated pathway is essential for D-serine synthesis by generating mice with a conditional deletion of D-3-phosphoglycerate dehydrogenase (Phgdh; EC 1.1.1.95). This enzyme catalyzes the first step in L-serine synthesis via the phosphorylated pathway. HPLC analysis of serine enantiomers demonstrated that both L- and D-serine levels were markedly decreased in the cerebral cortex and hippocampus of conditional knock-out mice, whereas the serine deficiency did not alter protein expression levels of serine racemase and NMDA receptor subunits in these regions. The present study provides definitive proof that L-serine-synthesized endogenously via the phosphorylated pathway is a key rate-limiting factor for maintaining steady-state levels of D-serine in adult brain. Furthermore, NMDA-evoked transcription of Arc, an immediate early gene, was diminished in the hippocampus of conditional knock-out mice. Thus, this study demonstrates that in mature neuronal circuits L-serine availability determines the rate of D-serine synthesis in the forebrain and controls NMDA receptor function at least in the hippocampus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
Glia-Derived d-Serine Controls NMDA Receptor Activity and Synaptic Memory
Panatier, A., Theodosis, D. T., Mothet, J.-P., Touquet, B., Pollegioni, L., Poulain, D. A., & Oliet, S. H. R. (2006) · Cell · doi:10.1016/j.cell.2006.02.051 · Cited by 934
NMDA receptors, place cells and hippocampal spatial memory
Nakazawa, K., McHugh, T. J., Wilson, M. A., & Tonegawa, S. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1385 · Cited by 619
Schell, M. J., Brady Jr., R. O., Molliver, M. E., & Snyder, S. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01604.1997 · Cited by 415
Enzymes of serine metabolism in normal, developing and neoplastic rat tissues
Snell, K. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90021-9 · Cited by 267
Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L. H., & Iyo, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.023 · Cited by 267
Yoshida, K., Furuya, S., Osuka, S., Mitoma, J., Shinoda, Y., Watanabe, M., Azuma, N., Tanaka, H., Hashikawa, T., Itohara, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300507200 · Cited by 161
Self-citation
Research works printed but not linked: 55
- Scheetz, 1994, FASEB J., 8, 745, 10.1096/fasebj.8.10.8050674 · DOI · Paper page
- Johnson, 1987, Nature., 325, 529, 10.1038/325529a0 · DOI · Paper page
- Kleckner, 1988, Science., 241, 835, 10.1126/science.2841759 · DOI · Paper page
- Danysz, 1998, Pharmacol. Rev., 50, 597, 10.1016/S0031-6997(24)01382-6 · DOI · Paper page
- Hashimoto, 1992, FEBS Lett., 296, 33, 10.1016/0014-5793(92)80397-Y · DOI · Paper page
- Hashimoto, 1997, Prog. Neurobiol., 52, 325, 10.1016/S0301-0082(97)00019-1 · DOI · Paper page
- Boehning, 2003, Annu. Rev. Neurosci., 26, 105, 10.1146/annurev.neuro.26.041002.131047 · DOI · Paper page
- Nishikawa, 2005, Biol. Pharm. Bull., 28, 1561, 10.1248/bpb.28.1561 · DOI
- Wolosker, 2008, FEBS J., 275, 3514, 10.1111/j.1742-4658.2008.06515.x · DOI · Paper page
- Hashimoto, 1993, J. Neurochem., 60, 783, 10.1111/j.1471-4159.1993.tb03219.x · DOI · Paper page
- Matsui, 1995, J. Neurochem., 65, 454, 10.1046/j.1471-4159.1995.65010454.x · DOI · Paper page
- Mothet, 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 4926, 10.1073/pnas.97.9.4926 · DOI · Paper page
- Wood, 1989, J. Neurochem., 53, 979, 10.1111/j.1471-4159.1989.tb11803.x · DOI
- Contreras, 1990, Neuropharmacology., 29, 291, 10.1016/0028-3908(90)90015-J · DOI
- Tanii, 1994, J. Pharmacol. Exp. Ther., 269, 1040, 10.1016/S0022-3565(25)38840-3 · DOI
- Tsai, 1998, Biol. Psychiatry., 44, 1081, 10.1016/S0006-3223(98)00279-0 · DOI · Paper page
- Heresco-Levy, 2005, Biol. Psychiatry., 57, 577, 10.1016/j.biopsych.2004.12.037 · DOI · Paper page
- Javitt, 2004, Mol. Psychiatry., 9, 984, 10.1038/sj.mp.4001551 · DOI · Paper page
- Wolosker, 1999, Proc. Natl. Acad. Sci. U.S.A., 96, 721, 10.1073/pnas.96.2.721 · DOI · Paper page
- Cook, 2002, J. Biol. Chem., 277, 27782, 10.1074/jbc.M111814200 · DOI
- De Miranda, 2002, Proc. Natl. Acad. Sci. U.S.A., 99, 14542, 10.1073/pnas.222421299 · DOI · Paper page
- Neidle, 2002, Neurochem. Res., 27, 1719, 10.1023/A:1021607715824 · DOI
- Strísovský, 2003, FEBS Lett., 535, 44, 10.1016/S0014-5793(02)03855-3 · DOI
- Foltyn, 2005, J. Biol. Chem., 280, 1754, 10.1074/jbc.M405726200 · DOI · Paper page
- Dunlop, 1997, Biochem. Biophys. Res. Commun., 235, 26, 10.1006/bbrc.1997.6724 · DOI
- Inoue, 2008, J. Neurosci., 28, 14486, 10.1523/JNEUROSCI.5034-08.2008 · DOI · Paper page
- Basu, 2009, Mol. Psychiatry., 14, 719, 10.1038/mp.2008.130 · DOI · Paper page
- Labrie, 2009, Hum Mol. Genet., 18, 3227, 10.1093/hmg/ddp261 · DOI · Paper page
- Hirabayashi, 2008, Prog. Lipid Res., 47, 188, 10.1016/j.plipres.2008.01.003 · DOI
- Furuya, 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 11528, 10.1073/pnas.200364497 · DOI · Paper page
- Yamasaki, 2001, J. Neurosci., 21, 7691, 10.1523/JNEUROSCI.21-19-07691.2001 · DOI · Paper page
- de Koning, 2006, J. Inherit. Metab. Dis., 29, 347, 10.1007/s10545-006-0269-0 · DOI
- Fuchs, 2006, Ann. Neurol., 60, 476, 10.1002/ana.20977 · DOI
- Zhuo, 2001, Genesis., 31, 85, 10.1002/gene.10008 · DOI · Paper page
- Holzenberger, 2000, Nucleic. Acids Res., 28, E92, 10.1093/nar/28.21.e92 · DOI · Paper page
- Furuya, 2008, Funct. Integr. Genomics., 8, 235, 10.1007/s10142-007-0072-5 · DOI
- Kawakami, 2009, Neurosci. Res., 63, 184, 10.1016/j.neures.2008.12.002 · DOI
- Morikawa, 2003, Anal. Biochem., 312, 66, 10.1016/S0003-2697(02)00432-3 · DOI
- Abe, 2004, J. Neurosci., 24, 7292, 10.1523/JNEUROSCI.1261-04.2004 · DOI · Paper page
- Watanabe, 1998, Eur. J. Neurosci., 10, 478, 10.1046/j.1460-9568.1998.00063.x · DOI · Paper page
- Menniti, 2000, Neuropharmacology., 39, 1147, 10.1016/S0028-3908(99)00211-7 · DOI
- Cho, 2000, Gene., 245, 193, 10.1016/S0378-1119(00)00009-3 · DOI
- Klomp, 2000, Am. J. Hum. Genet., 67, 1389, 10.1086/316886 · DOI
- Takasaki, 2007, Biomed. Res., 28, 61, 10.2220/biomedres.28.61 · DOI
- Kartvelishvily, 2006, J. Biol. Chem., 281, 14151, 10.1074/jbc.M512927200 · DOI · Paper page
- Miya, 2008, J. Comp. Neurol., 510, 641, 10.1002/cne.21822 · DOI · Paper page
- Link, 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 5734, 10.1073/pnas.92.12.5734 · DOI · Paper page
- Lyford, 1995, Neuron., 14, 433, 10.1016/0896-6273(95)90299-6 · DOI · Paper page
- Coba, 2008, J. Biol. Chem., 283, 34101, 10.1074/jbc.M804951200 · DOI · Paper page
- Mitoma, 1998, Neurosci. Res., 30, 195, 10.1016/S0168-0102(97)00113-2 · DOI
- Yoshikawa, 2008, J. Pharmacol. Sci., 107, 270, 10.1254/jphs.08030FP · DOI
- Mustafa, 2010, J. Neurosci., 30, 1413, 10.1523/JNEUROSCI.4297-09.2010 · DOI
- Oldendorf, 1971, Am. J. Physiol., 221, 1629, 10.1152/ajplegacy.1971.221.6.1629 · DOI · Paper page
- Smith, 1987, J. Neurochem., 49, 1651, 10.1111/j.1471-4159.1987.tb01039.x · DOI · Paper page
- Bendikov, 2007, Schizophr. Res., 90, 41, 10.1016/j.schres.2006.10.010 · DOI · Paper page
Cited by
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
Astrocyte-neuron metabolic cooperation shapes brain activity
Bonvento, G., & Bolaños, J. P. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.006 · Cited by 580
Wei, L., Lee, D., Law, C.-T., Zhang, M. S., Shen, J., Chin, D. W.-C., Zhang, A., Tsang, F. H.-C., Wong, C. L.-S., Ng, I. O.-L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12606-7 · Cited by 428
Phosphatidylserine in the brain: Metabolism and function
Kim, H.-Y., Huang, B. X., & Spector, A. A. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.06.002 · Cited by 389
“This augments the affinity of the receptor for glutamate and thereby increases synaptic plasticity in the hippocampus [72].”
Glutamate hypothesis in schizophrenia
Uno, Y., & Coyle, J. T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12823 · Cited by 367
Le Douce, J., Maugard, M., Veran, J., Matos, M., Jégo, P., Vigneron, P.-A., Faivre, E., Toussay, X., Vandenberghe, M., Balbastre, Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.004 · Cited by 328
Self-citationThe NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in Pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 285
Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study
Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Sawaki, E., Koga, Y., & Benno, Y. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00009 · Cited by 227
“Thus, depletion of d-Ser levels has been implicated in NMDA receptor hypofunction, which is thought to occur in schizophrenia (Yang et al., 2010).”
The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.004 · Cited by 208
“D-Serine is synthesized almost exclusively by SR [10] using Lserine that is synthesized by the astrocytic enzyme, 3phosphoglycerate dehydrogenase [11 ,12].”
Serine one-carbon catabolism with formate overflow
Meiser, J., Tumanov, S., Maddocks, O., Labuschagne, C. F., Athineos, D., Van Den Broek, N., Mackay, G. M., Gottlieb, E., Blyth, K., Vousden, K., et al. (2016) · Science Advances · doi:10.1126/sciadv.1601273 · Cited by 174
D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase
Ehmsen, J. T., Ma, T. M., Sason, H., Rosenberg, D., Ogo, T., Furuya, S., Snyder, S. H., & Wolosker, H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4914-12.2013 · Cited by 118
Moaddel, R., Luckenbaugh, D. A., Xie, Y., Villaseñor, A., Brutsche, N. E., Machado-Vieira, R., Ramamoorthy, A., Lorenzo, M. P., Garcia, A., Bernier, M., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3669-0 · Cited by 86
Serine-dependent redox homeostasis regulates glioblastoma cell survival
Engel, A. L., Lorenz, N. I., Klann, K., Münch, C., Depner, C., Steinbach, J. P., Ronellenfitsch, M. W., & Luger, A.-L. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0794-x · Cited by 85
Metadata
- Authors
- Yang, J. H., Wada, A., Yoshida, K., Miyoshi, Y., Sayano, T., Esaki, K., Kinoshita, M. O., Tomonaga, S., Azuma, N., Watanabe, M., Hamase, K., Zaitsu, K., Machida, T., Messing, A., Itohara, S., Hirabayashi, Y., & Furuya, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 285
- Issue
- 53
- Pages
- 41380-41390
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2149932734
- Cited by
- 146
- References
- 7
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3602 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.